| abstract |
The invention provides an antibody and an siRNA against the ANGPTL4 protein capable of neutralizing proliferation and methods of making and using the same. The antibody and siRNA of the invention are further directed to the C terminal region of the protein and may be capable of neutralizing cell proliferation and treating cancer. The antibody may be a monoclonal and/or a humanized antibody. |